Botanical species · safety record

Yucca schidigera

The EFSA Compendium of Botanicals holds 2 constituent measurements and 6 adverse-effect records for Yucca schidigera. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Yucca schidigera Roezl ex Ortgies

2Constituent measurements
6Safety records
3Cited sources
35Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 35 licensed products naming Yucca schidigera as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry

Source material stated

  • Root
  • Root (powder)
  • Root extract
  • Stem
  • Trunk bark
  • Yucca schidigera

What the records describe

Constituents measured

  • Saponins1
  • Steroidal saponins1

Plant parts

  • Aerial part of plants6
  • Bark1
  • Unspecified1

Preparations

  • Solvent extraction1

Effect types

  • Hepatotoxicity2
  • Nephrotoxicity2
  • Other toxicities2

Target tissues

  • Digestive2
  • Urogenital2

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
SaponinsUnspecified10 PercentUnspecifiedResolve DOI
Steroidal saponinsBarkSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
HepatotoxicityDigestiveAerial part of plantsRuminants (generic) (as animal)Short-term toxicityResolve DOI
HepatotoxicityDigestiveAerial part of plantsRuminants (generic) (as animal)Short-term toxicityResolve DOI
NephrotoxicityUrogenitalAerial part of plantsRuminants (generic) (as animal)Short-term toxicityResolve DOI
NephrotoxicityUrogenitalAerial part of plantsRuminants (generic) (as animal)Short-term toxicityResolve DOI
Other toxicitiesAerial part of plantsRuminants (generic) (as animal)Short-term toxicityResolve DOI
Other toxicitiesAerial part of plantsRuminants (generic) (as animal)Short-term toxicityResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Benchaar, C., Chouinard, P. Y. Assessment of the potential of cinnamaldehyde, condensed tannins, and saponins to modify milk fatty acid composition of dairy cows . Journal of dairy science, 2009, vol. 92, no. 7, p. 3392-3396. DOI
  2. Oleszek, W., Sitek, M., Stochmal, A., Piacente, S., Pizza, C., Cheeke, P. Steroidal saponins of Yucca schidigera Roezl.. Journal of agricultural and food chemistry, 2001, vol. 49, no. 9, p. 4392-4396. DOI
  3. Wisloff, Helene., Uhlig, Silvio., Scheie, Eldri., Loader, Jared., Wilkins, Alistair., Flaoyen, Arne. Toxicity testing of saponin-containing Yucca schidigera Roetzl. juice in relation to hepato- and nephrotoxicity of Narthecium ossifragum (L.) Huds . Toxicon, 2008, vol. 51, no. 1, p. 140-150. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue